What are the NCCN guidelines for evaluation of asymptomatic women with early-stage breast cancer (stages I–IIB)?

Updated: Dec 27, 2019
  • Author: Pavani Chalasani, MD, MPH; Chief Editor: John V Kiluk, MD, FACS  more...
  • Print
Answer

The NCCN guidelines [77] recommend the following laboratory studies for all asymptomatic women with early-stage breast cancer (stages I–IIB):

  • Complete blood count (CBC) with differential
  • Comprehensive metabolic panel, with liver function tests (LFTs) and alkaline phosphatase

Additional studies indicated in specific settings include the following:

  • Bone scan, in patients with localized bone pain or alkaline phosphatase elevation
  •  Abdominal ± pelvic diagnostic CT with contrast or MRI with contrast, in patients with elevated alkaline phosphatase, abnormal liver function tests, abdominal symptoms, or abnormal physical examination of the abdomen or pelvis
  • Chest diagnostic CT with contrast, in patients with pulmonary symptoms

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!